Group HF and Merck & Co. Inc.’s Schering-Plough were among five companies that paid a total of $25.2 million to settle claims that they overcharged Louisiana for drugs for low-income patients. The two companies and Boehringer Ingelheim GmbH, Dey Pharma LP
• Pharma News
Powered By DaylifeOther company news pages:
- Abbott Labs
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Glaxo
- Roche
- J&J
- Merck
- Novartis
- Pfizer
- Sanofi-Aventis
- Schering-Plough
- Wyeth
Schering Plough Corp News
Actavis, 4 Drugmakers to Pay $25.2 Mln in Louisiana Settlement
Boehringer Ingelheim, Dey, GlaxoSmithKline and Schering-Plough agreed to pay Louisiana a combined total of $25.2 million to settle claims of unlawful inflation of drug costs, Louisiana Attorney General Buddy Caldwell said in an e-mailed statement. To contact
Prometheus Announces New Chief Commercial Officer
President, Acute Coronary Syndromes Business Unit, General Manager of Commercial and Manufacturing Operations for Schering-Plough in Portugal, Vice President of Managed Care and Vice President, Cardiovascular Business Unit. Additional industry experience includes
News page is in maintenance. Sorry for the inconvenience.
Clear
Clear